Enteral Feeding Intolerance (EFI)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Enteral Feeding Intolerance (EFI) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07518095

Serum Bicarbonate and Enteral Feeding Intolerance in Adult ICU: A Prospective Clinical Trial

This prospective, observational study evaluates whether serum bicarbonate HCO3 levels can predict enteral nutrition intolerance (EFI) in adult ICU patients.Obje…

Turkey (Türkiye)70 participantsStarted 2026-04-15

Treatment: Enteral Nutrition Intolerance (EFI)

TerminatedPhase 2

NCT03477903

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

The purpose of this study is to assess the treatment effect of intravenous TAK-954 in improving the average daily protein adequacy received through enteral nutr…

United States1 participantsStarted 2018-08-25

Treatment: TAK-954, Metoclopramide

CompletedPhase 2

NCT02784392

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The…

The purpose of this study is to evaluate the effect Ulimorelin in patients with enteral feeding intolerance.

United States, Netherlands, Spain120 participantsStarted 2016-10

Treatment: Ulimorelin, Metoclopramide